Département d'Immuno-Hématologie, Inserm U. 1016, Institut Cochin, Paris, France.
Département d'Immuno-Hématologie, Inserm U. 1016, Institut Cochin, Paris, France; Service d'Hématologie et d'Immunologie, Hôpital Ambroise Paré, Boulogne, France; UFR Sciences de la Santé, Université de Versailles SQY, Versailles, France.
Exp Hematol. 2018 Jul;63:22-27.e3. doi: 10.1016/j.exphem.2018.04.001. Epub 2018 Apr 12.
Animal evidence that platelet production occurs in the lungs is growing. We have investigated whether there is evidence to support pulmonary platelet production from studies using human conditions. We documented the presence of megakaryocytes (MKs) in the human pulmonary circulation and analyzed the role of the vascular microenvironment on MK function. Our results suggest that the endothelial microenvironment favors platelet formation and that von Willebrand factor combined with appropriate physical forces in flowing blood are determinant for platelet release. We also demonstrate that MKs have the potential to change ploidy as they circulate. These findings demonstrate a new pathophysiological environment affecting platelet production and provide new targets for therapeutic intervention.
越来越多的动物实验证据表明,血小板的生成发生在肺部。我们研究了是否有人类相关研究结果来支持肺部的血小板生成。我们记录了人类肺循环中巨核细胞(MK)的存在,并分析了血管微环境对 MK 功能的作用。结果表明,内皮细胞微环境有利于血小板的形成,而血管性血友病因子(von Willebrand factor,vWF)与血流中的适当物理力结合是血小板释放的决定因素。我们还证明,MK 在循环过程中具有改变倍性的潜力。这些发现揭示了一个新的影响血小板生成的病理生理学环境,并为治疗干预提供了新的靶点。